Cannabis Law Report

MAY 6, 2022

At this time the FDA has not evaluated what, if anything, these products are effective for and what appropriate doses might be, or whether there are counterindications for persons taking other drugs or having any other health conditions. Pre-clinical data support the possible use of CBD with Panic Disorder…Bipolar Disorder.”.

THC 52

THC CBD Media Food 52

Puff Puff Post

MARCH 2, 2020

Source: New Frontier Data). · Domestic quotas represent a further milestone in the Company’s stated timeline to bring the first medical cannabis products to market in Colombia, targeting patients with two priority conditions; chronic pain and nausea associated with chemotherapy. SOURCE Khiron Life Sciences Corp.

Extraction 40

Extraction THC Chronic Pain Cultivation 40

Cannabis Law Report

NOVEMBER 9, 2021

Delic expects to drive considerable patients to KWC through its media platform and build on the existing national leadership position already in place. With the addition of KWC, we can now reach millions of people suffering from various mental health conditions who have lost hope of finding effective, affordable treatments.

Treatment 52

Treatment Therapy Media Access 52

The Cannigma

OCTOBER 22, 2023

The Cannigma has always taken a data-informed approach to content creation – though up until recently we’ve been primarily leaning on the existing peer-reviewed literature to guide our content. We need more data – human data – on specific applications for the plant – symptoms, use cases, conditions and patient types.

Data 88

Data Research and Development Sleep Collective 88

Cannabis Law Report

SEPTEMBER 13, 2021

Positive data from this important study would significantly advance MYMD-1’s potential to become a blockbuster drug for inflammation and aging.”. The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy. Media: media@mymd.com. Chief Scientific Officer.

Clinical Trials 52

Clinical Trials Pharmaceutical Research and Development Therapy 52

Cannabis Law Report

JULY 24, 2019

Curaleaf CURLF, -7.27% is “illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety, among other conditions or diseases,” the FDA wrote. Chronic or arthritic pain.”. Full Letter.

CBD 51

CBD Tincture Pets Chronic Pain 51

Kind Meds (Cannabis Education Blog)

FEBRUARY 24, 2022

was created to perpetuate this stereotype, the federal government had initiated a federal ban, and media portrayal of its so-called ill-effects helped convince many legislators to vote in its favor. Throughout the 20th century, the “stoner” stereotype was often portrayed in the media. Emerald Group Publishing Limited. Moscowitz, L.,

Marijuana 52

Marijuana Research and Development Sleep Strains 52

StrainConnect

APRIL 23, 2019

Myrcene is also excellent for reducing inflammation and chronic pain and is a great way to open your receptors to accept cannabinoids. Please email support@strainconnect.com or try us on social media. Consult with a physician before use if you have a serious medical condition or use prescription medications. Share by:

Terpenes 63

Terpenes Cannabinoids Therapy Hybrid 63

FloridaMarijuana.net

AUGUST 13, 2018

Even mainstream media has profiled the medicinal effects of cannabis. No data was collected on sex or race/ethnicity. Almost all respondents (97%) used medical cannabis primarily for relief of chronic pain. Sleep improvement is a primary motivator for many patients who are utilizing medical cannabis. The mean age was 49.3

Sleep 180

Sleep Chronic Pain Marijuana Cannabinoids 180

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. Media representations can offer insights into the nature of the discourse about new medical products and therapies and how ideas and understandings about social phenomena become constructed. Background. Bonini et al.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

SEPTEMBER 1, 2022

AUSTIN, Texas, August 31, 2022 –( BUSINESS WIRE )–As Pain Awareness Month begins, Texas Original is calling on Texas’ legislature to add chronic pain as a qualifying condition to the state’s Compassionate Use Program (CUP). “The data is clear. For Media Inquiries Only: Callie Neatherlin.

Chronic Pain 52

Chronic Pain Programs Patients Conditions 52

Puff Puff Post

SEPTEMBER 16, 2019

Media are invited to attend an open house to learn more about the program and visit the recently expanded Santé Cannabis clinic and research centre in Montréal including a guided tour. RSVP: If you’d like to attend, please RSVP with Lilia Rassoul ( media@santecannabis.ca ). 71,000+ interactions with healthcare professionals.

Programs 108

Programs Research and Development Education Treatment 108

The Cannigma

APRIL 8, 2021

The doctor diagnoses the condition and chooses a specific medicine. CP: I’m going to say yes and it’s hard to tie this together, but there’s actually some really good animal, and a little bit of human data to support this. We don’t have any data if someone is using a Type III-high CBD strain in pregnancy.

Medicine 108

Medicine Cannabinoids Cannabis THC 108

Cannabis Law Report

AUGUST 31, 2022

AUSTIN, Texas–(BUSINESS WIRE)–As Pain Awareness Month begins, Texas Original is calling on Texas’ legislature to add chronic pain as a qualifying condition to the state’s Compassionate Use Program (CUP). 1 reason patients seek medical cannabis is to augment their pain management treatment.

Chronic Pain 52

Chronic Pain Programs Patients Conditions 52

Cannabis Law Report

JULY 12, 2019

As reported in the Guardian, Analytical Cannabis emphasises the importance of this for those suffering from conditions such as chronic pain, epilepsy and neurological and psychiatric disorders who have long been seeking access to what they hope is a transformative medicine.

Epilepsy 40

Epilepsy Medicine Clinical Trials Chronic Pain 40

Puff Puff Post

SEPTEMBER 16, 2019

Media are invited to attend an open house to learn more about the program and visit the recently expanded Santé Cannabis clinic and research centre in Montréal including a guided tour. RSVP: If you’d like to attend, please RSVP with Lilia Rassoul ( media@santecannabis.ca ). 71,000+ interactions with healthcare professionals.

Programs 40

Programs Research and Development Education Treatment 40

The Cannigma

JANUARY 19, 2022

We think now that as more and more data is becoming available, the cannabis could be a very useful treatment both THC and CBD have shown promise in helping with the inflammation and some of the damage that has occurred in the brain. Does your social media activity kind of fall into that a lot and what other channels are you using?

Patients 83

Patients Compliance Compliance Cannabis 83

StrainConnect

FEBRUARY 8, 2019

Please email support@strainconnect.com or try us on social media. Consult with a physician before use if you have a serious medical condition or use prescription medications. Privacy Policy and all Terms & Conditions printed on this site. Dont modify these 3 pswp__item elements, data is added later on. -->.

Hemp 57

Hemp CBD Cannabinoids Sativa 57

SpeedWeed

APRIL 23, 2021

While the cannabis community was reveling in its celebration of the plant, Talarico turned to social media to share the news of a bill he filed last month. To back up his push for Texas cannabis legalization, he went on to share public opinion data collected by the Texas Tribune in a recent survey, tweeting “this is a popular bipartisan idea.

Legalization 52

Legalization Chronic Pain Policy Legislation 52